Pedro A. de Alarcon MD » Department Chair

Home/Departments/Pediatrics/Pedro A. de Alarcon MD » Department Chair
Pedro A. de Alarcon MD » Department Chair 2017-08-01T10:20:46+00:00

Pedro A. de Alarcon MD

William H. Albers Professor and Department Chair University of Illinois College of Medicine PeoriaDepartment of Pediatrics
Work 530 NE Glen Oak Avenue Peoria IL 61637 Work Phone: 309-655-4242
Photo of Pedro A. de Alarcon MD

Biographical Info


Schedule an appointment for Chairman’s Clinic: 309-624-9844
Schedule an appointment for Hem/Onc: 309-624-4945


Education

MD – The George Washington University School of Medicine, Washington, DC (1972)
Internship and Residency – Department of Medicine, Washington Hospital Center, Washington, DC (1972-1974)
Residency – Department of Pediatrics, University of Vermont Medical Center, Burlington, Vermont (1974-1976)
Fellowship – State University of New York, Upstate Medical Center, Syracuse, New York (1976-1979)

Research Interests

Newborn megakaryocytopoiesis
Anemia of prematurity
Hemophilia/thrombophilia
Hodgkin lymphoma/BMT
Neuroblastoma associated opsoclonus-myoclonus-ataxia syndrome

Selected Publications

Cole P. Trippett T, Drachtman R, de Alarcón, P, Lu Chen, Schwartz C. AHOD0321: A COG Phase 2 Study of Weekly Gemcitabine and Vinorelbine for Children with Recurrent or Refractory Hodgkin Disease, A Children’s Oncology Group Report. J Clinical Oncology. ( 2009) 27 (9): 1456-61.

Schwartz CL, Constine LC, Villaluna D., London WB, Hutchison R, Sposto R, Lipshultz S, Turner C, de Alarcón P, Chauvenet A. A Risk-Adapted, Response-Based approach using ABVE-PC for Children and Adolescents with Intermediate and High Risk Hodgkin Lymphoma: The Results of P9425. Blood 2009 Sept 3; 114 (10): 2051-9 Epub 2009 Jul 7.

Al-Rahawan MM, de Alarcón PA. Gemcitabine and vinorelbine therapy for patients with Hodgkin lymphoma.Pediatric Health. 2009; 3(6): 525-532.

Leary S, Harrod V, de Alarcon P, Reiss, U. Low-Dose Systemic Thrombolytic Therapy for Deep Vein Thrombosis in Pediatric Patients. J Pediatr Hematol Oncol 2010; 32:97 -102

Cole P., McCarten KM, Drachtman R, de Alarcón P, Chen L, Trippett TM, Schwartz CL. Early FDG-PET-based Response Evaluation After Treatment with Gemcitabine and Vinorelbine for Refractory Hodgkin Disease: A Children’s Oncology Group Report. Journal Pediatric Hematology Oncology, Early Online: 1-8, 2010;

Day, S. W., Garcia, J., Antillon, F., Wilimas, J. A., McKeon, L. M., Carty, R. M., de Alarcon, P., Pui, C.-H., Ribeiro, R. C. and Howard, S. C. A Sustainable Model for Pediatric Oncology Nursing Education in Low-Income Countries. Pediatric Blood & Cancer. 2012; 58(2): 163-166 Epub 2011 Nov 18.


Categories: Pediatrics, UICOMP
Updated 2 months ago.